Nalaganje...
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
Missense mutations in LRRK2 (leucine-rich repeat kinase 2) are a major cause of PD (Parkinson's disease). Several antibodies against LRRK2 have been developed, but results using these polyclonal antibodies have varied widely leading to conflicting conclusions. To address this challenge, the Mic...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Portland Press Ltd.
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3682752/ https://ncbi.nlm.nih.gov/pubmed/23560750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20121742 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|